• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Design, Synthesis, and Preliminary Immunological Studies of MUC1-Based Antitumor Vaccines Adjuvanted with - and -FSL-1.基于MUC1的抗肿瘤疫苗与-和-FSL-1联合使用的设计、合成及初步免疫学研究。
ACS Med Chem Lett. 2020 Jun 22;11(7):1371-1376. doi: 10.1021/acsmedchemlett.9b00579. eCollection 2020 Jul 9.
2
Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapy.一种基于MUC1的三组分疫苗的设计，该疫苗用FSL-1作为佐剂用于癌症免疫治疗。
Medchemcomm. 2019 Jul 12;10(12):2073-2077. doi: 10.1039/c9md00254e. eCollection 2019 Dec 1.
3
Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.成纤维细胞刺激肽-1 作为一种潜在的黏膜佐剂增强肠道病毒 71 疫苗的黏膜和全身免疫应答。
Vaccine. 2018 Jul 5;36(29):4331-4338. doi: 10.1016/j.vaccine.2018.05.090. Epub 2018 Jun 8.
4
Development of -Acetylated Dipalmitoyl--Glyceryl Cysteine Analogs as Efficient TLR2/TLR6 Agonists.合成具有乙酰化二棕榈酰基-甘氨酰半胱氨酸类似物作为高效 TLR2/TLR6 激动剂。
Molecules. 2019 Sep 27;24(19):3512. doi: 10.3390/molecules24193512.
5
Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccine.半合成、自佐剂疫苗的开发：在天然条件下，高效、定点的 Sortase A 介导 Toll 样受体 2 配体 FSL-1 与重组蛋白抗原的连接及其在 A 组链球菌疫苗模型中的应用。
J Control Release. 2020 Jan 10;317:96-108. doi: 10.1016/j.jconrel.2019.11.018. Epub 2019 Nov 21.
6
Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern Bearing R/S-configured Pam3 CysSerLys4.具有不同糖基化模式且带有R/S构型Pam3 CysSerLys4的合成MUC1抗肿瘤疫苗候选物。
Chembiochem. 2016 Aug 3;17(15):1412-5. doi: 10.1002/cbic.201600206. Epub 2016 Jun 15.
7
Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein-Fusion Combination Vaccine.酶介导的、定点的方法将 Toll 样受体 2 激动剂偶联到蛋白抗原上的开发：朝着广泛保护性的、四组分的 A 组溶血性链球菌自佐剂化脂蛋白融合联合疫苗发展。
ACS Infect Dis. 2020 Jul 10;6(7):1770-1782. doi: 10.1021/acsinfecdis.0c00047. Epub 2020 Jun 1.
8
Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands.脂肽作为 Toll 样受体 2 配体的评价。
Curr Drug Deliv. 2017;14(7):935-943. doi: 10.2174/1567201813666160804114107.
9
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines.近期 MUC1 糖肽癌症疫苗的免疫评估。
Vaccines (Basel). 2016 Jul 26;4(3):25. doi: 10.3390/vaccines4030025.
10
Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population.用于组装基于自佐剂脂肽疫苗的模块化平台，用于杂种群中。
Vaccine. 2020 Jan 16;38(3):597-607. doi: 10.1016/j.vaccine.2019.10.055. Epub 2019 Nov 15.

引用本文的文献

1
Trichostatin A-modified vaccine provides superior protection against ovarian cancer formation and development.曲古抑菌素 A 修饰疫苗可提供针对卵巢癌形成和发展的更佳保护。
Braz J Med Biol Res. 2024 May 17;57:e12874. doi: 10.1590/1414-431X2024e12874. eCollection 2024.
2
Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2.推陈出新：巨噬细胞激活脂质肽 2 的免疫机制和应用前景。
Front Immunol. 2023 Jan 24;14:1113715. doi: 10.3389/fimmu.2023.1113715. eCollection 2023.

本文引用的文献

1
Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.二糖基化 MUC-1 糖肽病毒样颗粒缀合物的合成与免疫评价。
ACS Chem Biol. 2019 Oct 18;14(10):2176-2184. doi: 10.1021/acschembio.9b00381. Epub 2019 Sep 19.
2
Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid-Dependent Immunodominant Response.靶向黏蛋白 1 的脂质体抗肿瘤疫苗引发脂质依赖性免疫显性反应。
Chem Asian J. 2019 Jun 14;14(12):2116-2121. doi: 10.1002/asia.201900448. Epub 2019 May 21.
3
Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage.基于结构的强效肿瘤相关抗原设计：通过糖苷键处的单原子 O/S 或 O/Se 取代来调节肽呈递。
J Am Chem Soc. 2019 Mar 6;141(9):4063-4072. doi: 10.1021/jacs.8b13503. Epub 2019 Feb 20.
4
Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity.抗原可逆地与聚合糖佐剂结合，诱导保护性体液和细胞免疫。
Nat Mater. 2019 Feb;18(2):175-185. doi: 10.1038/s41563-018-0256-5. Epub 2019 Jan 14.
5
β-Glucan as an immune activator and a carrier in the construction of a synthetic MUC1 vaccine.β-葡聚糖作为一种免疫激活剂和载体在合成 MUC1 疫苗中的构建。
Chem Commun (Camb). 2018 Dec 20;55(2):253-256. doi: 10.1039/c8cc07691j.
6
Protective Epitope Discovery and Design of MUC1-based Vaccine for Effective Tumor Protections in Immunotolerant Mice.基于 MUC1 的疫苗保护性表位的发现和设计，用于免疫耐受小鼠的有效肿瘤保护。
J Am Chem Soc. 2018 Dec 5;140(48):16596-16609. doi: 10.1021/jacs.8b08473. Epub 2018 Nov 19.
7
Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses.基于包含 B 和 T 细胞表位及 Toll 样受体 7 激动剂的糖三肽核心的多组分构建物的设计、合成和免疫学评价，该构建物能引发强烈的免疫应答。
J Med Chem. 2018 Nov 8;61(21):9568-9582. doi: 10.1021/acs.jmedchem.8b00960. Epub 2018 Oct 23.
8
Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines.靶向 STING 的环状二鸟苷酸极大地增强了糖肽癌症疫苗的免疫反应。
Chem Commun (Camb). 2018 Aug 23;54(69):9655-9658. doi: 10.1039/c8cc04860f.
9
Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.成纤维细胞刺激肽-1 作为一种潜在的黏膜佐剂增强肠道病毒 71 疫苗的黏膜和全身免疫应答。
Vaccine. 2018 Jul 5;36(29):4331-4338. doi: 10.1016/j.vaccine.2018.05.090. Epub 2018 Jun 8.
10
The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer.氟代脯氨酸在 MUC1 抗原中的应用使前列腺癌患者的抗体能够得到有效检测。
J Am Chem Soc. 2017 Dec 20;139(50):18255-18261. doi: 10.1021/jacs.7b09447. Epub 2017 Dec 12.

基于MUC1的抗肿瘤疫苗与-和-FSL-1联合使用的设计、合成及初步免疫学研究。

Design, Synthesis, and Preliminary Immunological Studies of MUC1-Based Antitumor Vaccines Adjuvanted with - and -FSL-1.

作者信息

Liu Yonghui, Yan Bocheng, Wang Zhaoyu, Zhu Haomiao, Yin Xiaona, Wang Kun, Wang Menglei, Zhao Wei

机构信息

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University, No. 38 Tongyan Road, Haihe Education Park, Tianjin 300353, P. R. China.

出版信息

ACS Med Chem Lett. 2020 Jun 22;11(7):1371-1376. doi: 10.1021/acsmedchemlett.9b00579. eCollection 2020 Jul 9.

DOI:10.1021/acsmedchemlett.9b00579
PMID:32676142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7356377/
Abstract

Fibroblast stimulating lipopeptide 1 (FSL-1) is the ligand of TLR2 and TLR6 and can be used as the vaccine adjuvant to prepare antitumor vaccines. However, FSL-1 is a stereoisomeric mixture that contains the stereoisomer and stereoisomer, and it is still unclear which stereoisomer has better adjuvant activities. In this work, we designed and synthesized MUC1-based antitumor vaccines adjuvanted with the stereoisomers -FSL-1 and -FSL-1, which were synthesized from the stereoisomeric building blocks -Fmoc-PamCys-OH and -Fmoc-PamCys-OH, respectively. Immunological evaluation indicated that both -FSL-1 and -FSL-1 can be used as adjuvants for the construction of MUC1-based antitumor vaccines, with -FSL-1 showing a better adjuvant effect than -FSL-1.

摘要

成纤维细胞刺激脂肽1（FSL-1）是Toll样受体2（TLR2）和Toll样受体6（TLR6）的配体，可作为疫苗佐剂用于制备抗肿瘤疫苗。然而，FSL-1是一种立体异构体混合物，包含立体异构体和立体异构体，目前仍不清楚哪种立体异构体具有更好的佐剂活性。在本研究中，我们设计并合成了基于粘蛋白1（MUC1）的抗肿瘤疫苗，分别用立体异构体-FSL-1和-FSL-1作为佐剂，它们分别由立体异构的构建模块-Fmoc-PamCys-OH和-Fmoc-PamCys-OH合成。免疫学评估表明，-FSL-1和-FSL-1均可作为构建基于MUC1的抗肿瘤疫苗的佐剂，其中-FSL-1的佐剂效果优于-FSL-1。